263
panel
Future of Health Summit Reception
panel
Future of Health Summit Closing Reception
panel
A Revolution in Longevity Science
People are living longer than ever before. On average, across OECD countries, at age 65, people
can expect to live another 19.7 years. By the year 2050, there will be eight times as many centenarians as there are today.
+ Read More
panel
At the Crossroads: Public Health and Climate Change
Global advocacy to address the threat of climate change has become one of the leading social mov
ements of our age.
+ Read More
panel
Foundations as Trusted Intermediaries for Patient Data Resources
Analyzing data from and about patients is essential to advance biomedical research, but its coll
ection and dissemination require significant investment of time and resources for patient organizations that choose to be the intermediary.
+ Read More
panel
High-Tech and High-Touch: Solutions to Support Caregivers
One need not look far to find one of the 50 million family caregivers in America. They are criti
cal to meeting the needs of our aging population.
+ Read More
panel
Reimagining the Pharmaceutical Supply Chain in the United States
Ideally, our nation's pharmaceutical supply chain should provide medicines and medical supplies
of the highest quality, in the right quantity, to the right customer at the right place.
+ Read More
panel
Tackling Chronic Disease: Creating Value and Impact through Upstream Intervention
Life expectancy in the US fell by 2.26 years from 2019 to 2022, the biggest drop since WW II.
panel
The Future of Senior Housing: Building for Health, Engagement, and Accessibility
According to a Milken Institute survey, affordable housing and connected health services are the
two most critical policy interventions that local leaders must prioritize before 2030, as they prepare for aging populations.
+ Read More
panel
The Path Forward for Patient-Focused Product Development and Use of Patient Input in Decision-Making
Consideration of patients' needs, experiences, and perspectives can contribute to medical produc
t development processes, as well as inform regulatory and access decision-making.
+ Read More